From last decade of the 20th century, numerous epidemiological studies and intervention trials have attempted to prove the relationships between maternal periodontal diseases and adverse pregnancy outcomes (APO). Periodontal diseases are considered a risk factor for APO, including preterm birth, fetal growth restriction, low birthweight, pre-eclampsia and gestational diabetes. However, the efficacy of periodontal treatment during pregnancy is controversial. Two pathogenic mechanisms might explain the potential effect of periodontal diseases on pregnancy outcomes. First, periodontal bacteria originating in the gingival biofilm directly affect the feto-placental unit subsequent to bacteremia. Second, inflammatory mediators secreted by the subgingival inflammatory site are carried to the feto-placental unit, where they then cause an inflammatory response. To elucidate these mechanisms, many researchers have been investigating the use of experimental animal models and in vitro models. In the present review, we summarize the current literature on the relationship between periodontal diseases and APO from epidemiological studies, animal models studies and in vitro studies, and speculate on the possible mechanism of periodontal diseases affecting pregnancy outcomes.
Introduction
Periodontal disease, or gum disease, is one of the most common chronic inflammatory disorders that affect the tissues surrounding the teeth (Fig. 1) . 1 Gingivitis is a mild form of periodontal disease that causes redness and swelling (inflammation) of the gingiva. Though gingivitis is localized to only the gingiva without destroying periodontal tissues, gingivitis can progress to serious gum disease called periodontitis. Periodontitis is a severe form of periodontal disease and induces inflammatory changes in the gingival epithelium, periodontal membrane, dental cement and alveolar bone (Fig. 2) . The loss of connective tissue and alveolar bone by periodontitis could lead to the loss of teeth. The prevalence of periodontitis is more than 50% of the adult population. 2 Periodontal diseases are caused by multiple gramnegative microaerophilic and anaerobic bacteria, such as Porphyromonas gingivalis, Fusobacterium nucleatum, Prevotella intermedia, Actinobacillus actinomycetemcomitans and Treponema denticola.
Recent epidemiological studies have suggested that periodontitis is a risk factor for other systemic diseases, including pneumonia, 3, 4 especially aspiration pneumonia in the elderly, 4 diabetes mellitus 5 and atherosclerosis. 6 Periodontal diseases are also regarded as a risk factor for pregnancy complications. In the last two decades, many researchers have investigated the relationship between periodontal diseases and various adverse pregnancy outcomes (APO). The potential effect of periodontal diseases might be explained by two mechanisms: the translocation of periodontal pathogens to the feto-placental unit, or the effect of inflammatory mediators, such as interleukin-1 (IL-1), IL-6, IL-8, tumor necrosis factor-α (TNF-α) or prostaglandin E 2 (PGE 2 ), on the fetoplacental unit. In this review article, we summarize the current literature on the relationship between periodontal diseases and APO from epidemiological studies, animal models and in vitro studies and speculate on the possible mechanism by which periodontal diseases affect pregnancy outcomes.
Epidemiological Results
Numerous epidemiological studies have suggested that maternal periodontal diseases are associated with an increased risk of various APO, including preterm birth (PTB), fetal growth restriction (FGR), low birthweight (LBW), pre-eclampsia (PE) and gestational diabetes (GDM) since 1996, when Offenbacher et al. first reported a relationship between periodontal diseases and preterm LBW (PLBW). 7 However, the association between maternal periodontal diseases and APO remains controversial because of various clinical parameters of APO and periodontitis assessment and the heterogeneity of enrolling subjects. Therefore, several researchers have attempted to reveal the relationship between periodontal diseases and APO by meta-analysis.
Regarding the involvement of periodontal disease in LBW or PTB, maternal periodontal disease seems to be modestly associated with PTB and LBW. [8] [9] [10] A meta-analysis of 17 peer-reviewed studies by Vergnes and Sixou revealed that periodontal disease was an independent risk factor for PLBW. 9 The odds ratio (OR) was 2.83 (95% confidence interval [CI] 1.95-4.10). 9 A systematic review and metaanalysis by Corbella et al. of 17 case-control studies that included a total of 10 148 patients found that the estimated OR was 1.78 (95% CI 1.58-2.01) for PTB, 1.82 (95% CI 1.20-1.51) for LBW and 3.00 (95% CI 1.93-4.68) for PLBW. 10 A stronger association between periodontitis and PE has been reported. A meta-analysis by Sgolastra et al. that included 15 studies found that a positive association between periodontal disease and PE (OR 2.17, 95% CI 1.38-3.41, P = 0.0008). 11 According to a meta-analysis and observational studies by Wei et al., a significant association between periodontal disease and PE was identified (OR 2.79, 95% CI 2.01-3.01, P < 0.0001).
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A recent meta-analysis indicated that periodontal disease is associated with an increasing risk of GDM among pregnant women compared to those without periodontal disease. Abariga and Whitcomb reported that their meta-analysis estimated more than twofold increased odds of GDM among women with periodontitis (OR 2.08, 95% CI 1.21-3.58, P = 0.009).
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A meta-analysis by Esteves Lima et al. indicated a significant association between periodontitis and GDM in the meta-analyses of four cross-sectional studies (OR 1.67, 95% CI 1.20-2.32) and two case-control studies (OR 2.66, 95% CI 1.52-4.65). However, with the inclusion of one case-control study, the significance was null (meta-analysis of three case-control studies: OR 1.69, 95% CI 0.68-4.21) because the sensitivity tests for these case-control studies showed a lack of consistency. Interestingly, recent epidemical studies have revealed that dental health status affects male infertility. 15, 16 A systematic review by Kellesarian et al. reported that results from six studies showed a positive association between chronic periodontitis and male infertility. 15 On the other hand, there are few reports about the relationship between female infertility and periodontal diseases.
According to the meta-analysis studies above, periodontal diseases might be associated with pregnancy complications. However, several case-control studies 17, 18 and cross-sectional studies 19 have shown no relationship between periodontal diseases and APO. Abati et al. reported that periodontitis and APO have no significant association, based on a multicentric epidemiologic study. 20 Due to variations in the risk factors for APO, we should be careful to understand the difference between correlation and causation between periodontal diseases and APO.
Clinically, the efficacy of dental intervention during pregnancy is controversial. Though some reports found efficacy of periodontal treatment during pregnancy in a high-risk group mothers, [21] [22] [23] most of the studies concluded that the treatment of periodontal diseases could not reduce the incidence of APO. [24] [25] [26] [27] [28] According to a systematic review with meta-analysis, nonsurgical periodontal therapy during pregnancy improved periodontal clinical findings; however, it did not reduce PTB or LBW. 29 Another systematic review and meta-analysis also concluded that treatment of periodontal diseases with scaling and root planing did not reduce the incidence of PTB (OR 1.15, 95% CI 0.95-1.40), LBW (OR 1.07, 95% CI 0.85-1.36) or spontaneous abortions/stillbirths (OR 0.79, 95% CI 0.51-1.22). 24 The association between periodontal treatment and GDM has not been established, while nonsurgical periodontal treatment did not decrease HbA1c levels in nonpregnant type 2 diabetes mellitus patients. 30 Since multiple factors, that is, maternal age, body weight, past history, smoking, obstetric history and socioeconomic factors, are associated with the incidence of APO, the analysis should be carefully designed. Another concern is that the definitions of periodontal diseases have varied depending on previous studies. 29 To elucidate the causation of periodontal diseases on APO incidence, randomized clinical trials and widely accepted diagnostic criteria for periodontal diseases that are of high methodological quality are needed.
Placental Microbiome and Pathogenic Oral Bacteria
Recent studies have revealed that the placenta is not sterile but instead has a unique microbiome. 31, 32 Stout et al. identified gram-positive and gram-negative intracellular bacteria in the basal plate of the human placenta. 32 Aagaard et al. investigated 320 placental subjects using 16S ribosomal DNA-based and wholegenome shotgun metagenomic technology. The results show that placental microbiome profiles are more related to the oral microbiome than other microbiomes in the human body, such as the gut, nares, skin and urogenital tract. 31 Although oral bacteria do not enter systemic circulation constantly, daily oral activities (e.g. tooth brushing and flossing) and dental treatments (e.g. scaling and root planing) often cause bacteremia. 33 Therefore, the feto-maternal units, especially invasive trophoblasts, are exposed to oral bacteria by chance. Not only nonpathogenic oral bacteria but also pathogenic bacteria could translocate to the placenta.
Periodontal diseases, including gingivitis and periodontitis, are attributed to interactions between the host immunity and multiple microbial species, including P. gingivalis, F. nucleatum, Pr. intermedia, A. actinomycetemcomitans, T. denticola, in the subgingival environment. Swati et al. reported that the DNA of periodontal pathogens was highly detectable in PE patients compared to controls. 34 P. gingivalis DNA was detected in chorionic tissues from hospitalized high-risk pregnant women. 35 Katz et al. identified the presence of P. gingivalis antigens in placental tissues and suggested that the colonization of P. gingivalis in the placenta might contribute to placental dysfunction. 36 Interestingly, Vanterpool et al. reported that the location of P. gingivalis within the placenta was different between preterm and term groups. Using immunofluorescent histology, P. gingivalis was detected in the villous mesenchyme in the preterm cohort, whereas P. gingivalis within the syncytiotrophoblasts was found in both preterm and term placentas. 37 Moreover, the presence of P. gingivalis in the umbilical cord was highly associated with PE. 37 Taken together, these findings suggest that presence of pathogenic oral bacteria in the placenta is related to APO. However, most studies have found that periodontal bacteria were detected in normal placentas without APO. Therefore, further studies are needed to describe the role of local periodontal bacteria in the placenta for the pathogenesis of APO.
Pathogenic Mechanisms of Periodontal Diseases and APO
Currently, two mechanisms are considered: the direct and indirect pathways (Fig. 3) . The oral microbiome and pathogenic periodontal bacteria are considered to disseminate to the feto-placental unit. Therefore, the direct roles of oral bacteria on APO have been investigated using experimental animal models and in vitro models. Another possible mechanism is that inflammatory mediators produced by infected periodontal tissue affect the feto-placental unit and myometrium.
Experimental Animal Models
To study the effect of periodontal diseases on pregnancy complications, pregnant animal models have been used. In several studies, P. gingivalis were infected using a small chamber. P. gingivalis-infected pregnant mice exhibited FGR and resorption, which was associated with an increase in the placental Th1/T2 cytokine ratio 38 and maternal TNF-α levels and a suppression of IL-10 levels. 39 In another study, dental infection with P. gingivalis induced PTB and LBW in pregnant mice 40 and significantly increased maternal levels of circulating TNF-α, IL-17, IL-6 and IL-1β. 40 Frequently observed histological findings of P. gingivalis-infected murine placenta were broad degenerative and focal necrotic changes. 40 Moreover, colonization of P. gingivalis was observed in the placenta of P. gingivalis-infected pregnant mice by immuohistchemistry. 40 P. gingivalis produces bioactive and pathogenic components, such as lipopolysaccharides (P. gingivalis lipopolysaccharide [Pg-LPS]) and gingipains-cysteine proteinases. These components of P. gingivalis could be associated with APO in pregnant animal models. Takii et al. proposed the possible roles of gingipain from their findings, including the reduction of PTB and pregnancy loss rate by the gingipain-deficient P. gingivalis strain and the therapeutic effects of gingipain inhibitors against P. gingivalis infection-induced fetal loss models. 41 In pregnant rat models, the administration of Pg-LPS increased maternal symbolic pressure, reduced placental weight and decreased fetal weight and fetal resorption. 42 These data from rodent models suggest that P. gingivalis infection in pregnant mothers lead to APO.
Although rodents are widely used in models of experimental periodontal disease, it is inadequate to determine whether the findings truly mimic human periodontal diseases because the jaw, maxilla and mandible of rodents are anatomically quite different from those of humans, and they have a distinct oral microbiome. 43 In addition, the placental structure of rodents is different from that of humans. In that respect, nonhuman primates, including the rhesus monkey, cynomolgus monkey and baboon, have oral structures, teeth and placenta similar to those of humans. These primates have naturally occurring dental plaque, calculus, oral microbial pathogens and periodontal diseases. 43 Ebersole et al. investigated periodontitis in pregnant baboons and found a significantly greater frequency of LBW and decreased Figure 3 Potential biological mechanisms of periodontal disease induces adverse pregnancy outcome. The pathophysiology of periodontal inflammation-related pregnancy complications could be explained by two mechanisms. The direct pathway is the dissemination of periodontal pathogens from periodontal pockets into the feto-placental unit. The indirect pathway is mediated by locally and systemically produced inflammatory mediators.
gestational age in the periodontitis group. 44 In addition, spontaneous abortion/stillbirth/fetal demise were increased in the periodontitis group. 44 The pregnant baboon model seems ideal for studying the association between periodontal diseases and pregnancy outcomes. However, animal experiments using nonhuman primate models are restricted due to ethical issues as well as the need for specific experimental facilities. Therefore, the baboon model is far from the standard animal pregnancy model with periodontal diseases.
So far, most experimental animal models showed APO caused by periodontal diseases; however, Fogacci et al. found no association between periodontitis and PTB and LBW in Wister rats. 45 
In Vitro Models
In vitro experiments have revealed the molecular mechanisms underlying periodontal disease-induced APO. To explore the local interaction between the placenta and periodontal pathogens, human trophoblast cell lines and periodontal bacteria or bacterial components have been widely used as in vitro models.
Infection with P. gingivalis in an extravillous trophoblast cell line (HTR-8) induced apoptosis and G1 arrest 46, 47 via ERK1/2, p38 and c-Jun N-terminal protein kinase pathways. 47, 48 Additionally, infection with P. gingivalis induced IL-8 and IFN-γ secretion in HTR-8 cells. 48 However, coculture of live P. gingivalis and live cells may be inadequate to investigate the effect of P. gingivalis on the trophoblast because of its anaerobic natures. Thus, bacterial components and/or products have also been used to examine the effects of P. gingivalis on the trophoblast. LPS is one of the major components of the outer membrane of gramnegative bacteria and has pathogenetic and immunostimulatory effects. Pg-LPS induced IL-6 and IL-8 production in chorion-derived cells via TLR-2 signaling. 35 Following the stimulation of HTR-8/Svneo cells with Pg-LPS, the expression of IL-8, TNF-α and COX-2 levels were elevated in an NF-κB-dependent manner. 40 The adequate invasion of the extravillous trophoblast is important for a successful pregnancy. We have reported that a combination of Pg-LPS and nicotine 49 or soluble factors of P. gingivalis metabolites 50 significantly reduced the invasive activity of HTR-8/Svneo cells, and the cell morphology changes. According to the data, P. gingivalis may suppress trophoblast invasion and subsequent vascular remodeling.
Inflammatory Mediators Produced by Gingival Submucosa
Another possible mechanism is that inflammatory mediators, in association with periodontal diseases, affect the feto-placental unit and myometrium. Periodontal inflammation induced by bacterial biofilm causes the production of local and systemic inflammatory mediators. In periodontal diseases, inflammatory cytokines and mediators, including IL-1β, IL-6, TNF-α and PGE 2 , were produced in subgingival area 51 and then entered systemic circulation. Inflammatory cytokines induce an acute phase response in the liver characterized by secretion of C-reactive protein and fibrinogen.
52 IL-1β and TNF-α concentrations in the serum were significantly increased among preconception women with moderate/severe periodontal diseases. 53 These inflammatory cytokines could activate decidual immune cells, and PGE 2 induces uterine contractions. High levels of serum and amniotic fluid inflammatory mediators were associated with APO, especially PTB. [54] [55] [56] A systematic review reported a positive association between APO and inflammatory mediator levels in gingival crevicular fluid, which is an inflammatory exudate from the gingival margin or within the gingival crevice. 57 According to the above result, systemic inflammatory status caused by periodontal diseases might induce local inflammatory responses in the feto-placental unit to increase the occurrence of APO.
Recent studies suggest possible involvement of alarmins, including uric acid, high-mobility group box 1 (HMGB1) and cell-free DNA, for pregnancy complications. 58 These molecules are released by the principal inflammatory site and cause sterile inflammation in gestational tissues. Alarmins produced by inflamed periodontal tissue may affect the feto-placental unit and induce APO.
Conclusion
Multiple factors are associated with the incidence of APO, and periodontal disorders are an independent risk factor, according to epidemiological and experimental studies. Periodontal bacteria, especially P. gingivalis, and their components can injure the trophoblast morphologically and functionally. Moreover, inflammatory mediators from periodontal pockets might elicit an inflammatory immune response at the feto-placental unit. However, periodontal treatment during pregnancy seems to have little effect on the prevention of APO incidence. Trophoblast cells migrate into the uterine myometrium and reconstruct the uteroplacental sinus during the early period of pregnancy, and the placental structure is completed in the first trimester. Therefore, although dental care is effective in curing periodontal diseases, dental care during pregnancy may occur too late to reduce pregnancy complications. Despite knowing the importance of oral hygiene, obstetricians, dentists and pregnant women themselves have a tendency to avoid invasive dental treatment during pregnancy for possible side effects. Therefore, oral health care and dental interventions before conception are strongly recommended.
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